← Back

In patients with an IBD-associated high transsphincteric fistula, is LIFT or advancement flap repair preferred to maximize healing while preserving sphincter function

DecisionNot yet clinician-reviewed

What is known

- A meta-analysis of AF and LIFT for cryptoglandular and Crohn's high perianal fistulas reported lower incontinence with LIFT (1.6%) than AF (7.8%) in CD fistulas. 1,2 - Systematic-review LIFT healing in CD is roughly 67–76%; AF healing in CD series is 59–80%, with a pooled ~64% mean at 29 months. 1,3,4 - A retrospective review (Tan et al.) after seton placement found AF success 93.5% vs LIFT 62.5% (p=0.006), but LIFT had fewer postoperative complications and is technically simpler. 3 - AF success in CD is limited to patients without proctitis or anorectal stenosis; LIFT applicability is limited by multiple tracts/branch points common in CD. 1,2

What is unknown / caveats

- Tan series favors AF for healing (93.5% vs 62.5%) while pooled series show comparable or LIFT-favorable profiles - No adequately powered head-to-head RCT of LIFT vs AF isolated to CD high transsphincteric fistulas in the retrieved evidence - CD healing data for both techniques rests largely on small series with variable follow-up and inconsistent incontinence measurement - AF outcomes are worse in CD than in cryptoglandular disease and require absence of proctitis/stenosis - The retrieved evidence does not resolve which technique maximizes healing in CD specifically.

## References

1. Rinebold E, Huang AL, Hahn SJ. How to Approach the Difficult Perineum in Crohn's Disease. Clin Colon Rectal Surg. 2025;38(2):148-159. PMID: 39944307.

2. Stellingwerf ME, van Praag EM, Tozer PJ, Bemelman WA, Buskens CJ. Systematic review and meta-analysis of endorectal advancement flap and ligation of the intersphincteric fistula tract for cryptoglandular and Crohn's high perianal fistulas. BJS Open. 2019;3(3):231-241. PMID: 31183438.

3. Busbait S. Surgical Management of Perianal Crohn's Disease: Current Evidence and Future Directions. Acta Inform Med. 2024;32(3-4):215-220. PMID: 40061009.

4. Wetwittayakhlang P, Al Khoury A, Hahn GD, Lakatos PL. The Optimal Management of Fistulizing Crohn's Disease: Evidence beyond Randomized Clinical Trials. J Clin Med. 2022;11(11). PMID: 35683433.

For educational use only — not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

---

_Draft — generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct._

Sources retrieved: PMID 40061009 · PMID 32537672 · PMID 35683433 · PMID 42038501 · PMID 39944307 · PMID 31183438 · PMID 28223835 · PMID 28276809

Reviewer notes

answered 2026-08-04 · corpus build 31c2f53f · faithfulness 0.9090909090909091